Inventor · disambiguated record
James E. Dowling
Also filed as: DOWLING JAMES · DOWLING JAMES E · DOWLING JAMES EDWARD
10 granted patents·11 pending applications·87 citations·filing 2000–2024
89Inventor score
Top patents by PatentIndex Score
21 records- 0195US11021480B2Inhibiting (α-V)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2020·Granted Jun 1, 2021·8 cites·2 claims
- 0294US11739087B2Inhibiting (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2021·Granted Aug 29, 2023·5 cites·9 claims
- 0389US11370773B1Inhibiting human integrin (alpha-4) (beta-7)MORPHIC THERAPEUTIC INC·Filed 2021·Granted Jun 28, 2022·2 cites·24 claims
- 0488US6649600B1Adenosine receptor antagonists and methods of making and using the sameBIOGEN INC·Filed 2000·Granted Nov 18, 2003·31 cites·38 claims
- 0585US12459942B2Inhibiting (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2024·Granted Nov 4, 2025·0 cites·18 claims
- 0684US8901307B2Chemical compounds 251DAKIN LESLIE·Filed 2009·Granted Dec 2, 2014·15 cites·5 claims
- 0784US6605600B1Adenosine receptor antagonists and methods of making and using the sameBIOGEN INC·Filed 2000·Granted Aug 12, 2003·18 cites·29 claims
- 0881US11104661B1Inhibiting human integrin (α-4) (β-7)MORPHIC THERAPEUTIC INC·Filed 2020·Granted Aug 31, 2021·1 cites·24 claims
- 0973US7674791B2Triazolopyrazines and methods of making and using the sameBIOGEN IDEC INC·Filed 2004·Granted Mar 9, 2010·7 cites·13 claims
- 1068US2020071322A1Inhibiting (alpha-v)(beta-6) integrinMORPHIC THERAPEUTIC INC·Filed 2019·Application pending·0 cites
- 1167US2020354359A1Inhibiting (alpha-v)(beta-6) integrinMORPHIC THERAPEUTIC INC·Filed 2020·Application pending·0 cites
- 1266US2009221821A1Adenosine receptor antagonists and methods of making and using the sameBIOGEN IDEC INC·Filed 2009·Application pending·0 cites
- 1361US2008004293A1Adenosine receptor antagonists and methods of making and using the sameBIOGEN IDEC INC·Filed 2007·Application pending·0 cites
- 1455US2005222179A1Adenosine receptor antagonists and methods of making and using the sameENSINGER CAROL L·Filed 2005·Application pending·0 cites
- 1555US2004067966A1Adenosine receptor antagonists and methods of making and using the sameBIOGEN INC·Filed 2003·Application pending·0 cites
- 1654US2003225038A1Adenosine receptor antagonists and methods of making and using the sameBIOGEN INC·Filed 2003·Application pending·0 cites
- 1752US7579354B2Adenosine receptor antagonists and methods of making and using the sameKIESMAN WILLIAM F·Filed 2006·Granted Aug 25, 2009·0 cites·39 claims
- 1852US2007015732A1Adenosine receptor antagonists and methods of making and using the sameKIESMAN WILLIAM F·Filed 2006·Application pending·0 cites
- 1951US2023219949A1Inhibitors of (alpha-v)(beta-6) integrinHARRISON BRYCE A·Filed 2022·Application pending·0 cites
- 2050US2012040951A1Heteroaryl compounds useful as raf kinase inhibitorsCHUAQUI CLAUDIO·Filed 2009·Application pending·0 cites
- 2149US2015051185A1Chemical Compounds 251ASTRAZENECA AB·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James E. Dowling files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →